Citigroup Inc Ocugen, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Ocugen, Inc. stock. As of the latest transaction made, Citigroup Inc holds 197,731 shares of OCGN stock, worth $179,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares

197,731

Previous 146,508 34.96%

Holding current value

$179,935

Previous $227,000 14.1%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.98 - $1.95 $50,198 - $99,884	51,223 Added 34.96%	197,731 $195,000
Q2 2024 Aug 12, 2024	BUY	$1.18 - $1.98 $143,287 - $240,431	121,430 Added 484.21%	146,508 $227,000
Q1 2024 May 10, 2024	BUY	$0.5 - $1.83 $12,457 - $45,592	24,914 Added 15191.46%	25,078 $41,000
Q4 2023 Feb 09, 2024	SELL	$0.36 - $0.57 $209 - $331	-581 Reduced 77.99%	164 $0
Q3 2023 Nov 09, 2023	SELL	$0.4 - $0.62 $60 - $93	-151 Reduced 16.85%	745 $0
Q2 2023 Aug 10, 2023	SELL	$0.45 - $0.88 $23,737 - $46,419	-52,749 Reduced 98.33%	896 $0
Q1 2023 May 11, 2023	SELL	$0.82 - $1.33 $893,453 - $1.45 Million	-1,089,577 Reduced 95.31%	53,645 $45,000
Q4 2022 Feb 09, 2023	SELL	$1.11 - $1.87 $726,558 - $1.22 Million	-654,557 Reduced 36.41%	1,143,222 $1.49 Million
Q3 2022 Nov 10, 2022	BUY	$1.75 - $3.1 $616,248 - $1.09 Million	352,142 Added 24.36%	1,797,779 $3.2 Million
Q2 2022 Aug 10, 2022	BUY	$1.83 - $3.45 $1.9 Million - $3.58 Million	1,036,249 Added 253.12%	1,445,637 $3.28 Million
Q1 2022 May 12, 2022	SELL	$2.34 - $4.72 $988,628 - $1.99 Million	-422,491 Reduced 50.79%	409,388 $1.35 Million
Q4 2021 Feb 10, 2022	BUY	$4.38 - $15.67 $2.07 Million - $7.4 Million	472,438 Added 131.44%	831,879 $3.79 Million
Q3 2021 Nov 10, 2021	BUY	$6.36 - $8.51 $2.29 Million - $3.06 Million	359,441 New	359,441 $2.58 Million

Others Institutions Holding OCGN

# of Institutions

125

Shares Held

78.3M

Call Options Held

535K

Put Options Held

523K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $197M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account